Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,011 total articles
Credo Technology is converting raw AI bandwidth demand into outsized revenue growth through SerDes chiplets and optical connectivity. Recent results and insider conviction support further upside, but the stock carries a high valuation and concentrated customer exposure. This trade idea proposes a mid-term long with a disciplined stop below the 50-d…
Disney has pulled back to the mid-$90s amid macro worries and a softer first half of 2026. At roughly $167B market cap, a P/E near 15 and $7.1B in free cash flow, the stock looks attractive for a disciplined long trade. I lay out an entry at $95.50, a stop at $90.00, and a target at $120.00 with a 180-trading-day outlook, balanced by concrete risks…
BitMine’s immersion-cooled hosting business is being priced like a cyclical relic despite tangible margin leverage and structural cost advantages. We upgrade to long: buy on weakness, use a tight stop to limit downside, and hold for a mid-term re-rating as operating wins and clearer NAV optics hit the tape.
CECO trades at a steep multiple today, but the combination with Thermon, a raised 2026 orders outlook above $1.5B, and identified cost synergies create a credible path to margin and revenue expansion. This trade idea outlines an actionable long with an entry at $84.45, a $95 target in the mid term (45 trading days), and a $74 stop to contain downsi…
Amphenol (APH) combines steady free cash flow, a dominant position in rugged and optical interconnects, and direct exposure to an accelerating AI/data-center buildout. Valuation is rich but not unreasonable given growth and cash generation. This trade targets $185 with a $150 stop, horizon 180 trading days.
Home BancShares is a profitable regional bank trading at a reasonable multiple, yielding about 2.9%, and recently closed a meaningful acquisition that boosts scale. Fundamentals (ROE 11%, EPS $2.38) and conservative leverage support a buy-for-appreciation-plus-income trade over the next 180 trading days.
Medtronic looks set to beat conservative guidance over the coming quarters. The shares trade at a reasonable PE (~22) with a $105B market cap, a 3.5% yield, and healthy free cash flow. Technicals are constructive and recent M&A and product tailwinds create multiple catalysts. This is a buy for a swing trade into a re-acceleration in growth, with cl…
Einride has moved past proofs-of-concept and is landing commercial rollouts for its electric and software-driven freight platform. Traction in recurring software and managed services, combined with expanding vehicle deployments, creates a reasonably asymmetric setup for a measured long. Trade plan favors a disciplined entry with a conservative stop…
Century Communities (CCS) is a well-capitalized national homebuilder trading at a modest P/E and P/B, paying a rising dividend and generating positive free cash flow. The thesis: buy at current levels and give the company time (up to 180 trading days) to compress execution risk and let housing demand in key Sunbelt markets support a re-rating. Entr…
Arm's dominant CPU architecture and an explicit roadmap into AI chips make it one of the highest-growth bets in semiconductors. At a $349B market cap and a trailing P/E north of 380, the stock is expensive on today's cash flows. Still, management's guidance for revenue to rise from $4.92B in 2026 to $25B by 2031 implies materially lower multiples i…
Seven & i reported an operating profit beat and management has rolled out domestic corporate actions aimed at margin improvement and cash return. We view this as a constructive setup for a mid-term long trade: operational momentum plus visible capital allocation can re-rate the stock versus its recent trading range. Entry, stop and target given bel…
Lyft is trading at a steep discount to its cash-generation profile and sits on constructive technicals. With TTM free cash flow around $1.12B, an enterprise value near $5.93B and bullish momentum, a measured long swing trade with a $21 target looks actionable. This idea lays out entry, stop, catalysts and risks for a mid-term (45 trading days) trad…
Vizsla Silver is trading well below the project’s implied value after a security incident knocked the stock in early 2026. With a robust feasibility study (US$1.8B after-tax NPV) and fresh working capital from a Mexican government institution, the risk/reward looks attractive for a mid-term trade. This idea lays out a clear entry at $3.15, a stop a…
NatWest (NWG) is executing a fast-moving wealth play after the Evelyn Partners acquisition while returning capital and sitting on value multiple compression. Technical momentum and a 4.8% yield make a measured long trade attractive over the next 45 trading days, but the trade carries execution and regulatory risks tied to integration and UK macro p…
Palisade Bio (PALI) is a clinical-stage biotech developing an orally delivered, colon-specific therapy for ulcerative colitis and potentially Crohn's disease. The stock trades at roughly $1.96 with a market cap near $340M and heavy short interest. We present a tactical long trade: entry $1.95, stop $1.40, target $3.20 over a mid-term 45 trading day…
Intuitive Machines (LUNR) looks positioned to cross the profitability threshold in the next 12-24 months. Strong Q1 revenue of $186.7M, a $1.1B backlog and a $500M share sale provide runway. The stock is down from its $46.75 52-week high to about $17 today, trading at an attractive risk/reward for a tactical long over the next 45 trading days as ex…
Enovix (ENVX) offers a rare mix: a cutting-edge silicon-anode battery technology that could drive multi-year revenue growth, and a market cap under $1.2B that leaves room for asymmetric upside if production ramps. The company carries meaningful execution and legal risks, but today's price near the 52-week low provides a pragmatic entry with a defin…
Sigma Lithium (SGML) is a low-cost hard-rock lithium producer with a near-term production ramp and recent offtake prepayments that materially de-risk liquidity. At a market cap near $1.32B and current trading around $12.34, the stock offers a directional trade into 2027 production growth with clear entry, stop and target levels.
Duolingo (DUOL) looks like a high-conviction recovery name that is already showing the fundamental signs investors wanted: accelerating engagement, rising paid subscribers and substantial free cash flow. The market punished DUOL for guided near-term monetization sacrifice; we see that as a tactical entry point. Trade plan: enter at $130.01, stop at…
Micron ($MU) is positioned to benefit from the next wave of AI infrastructure memory - High-Bandwidth Memory 4 (HBM4) - but the market is underestimating timing and revenue leverage. With a $1.12T market cap, strong cash flow, low leverage and recent strategic deals, a measured long trade into weakness targets a re-test of recent highs. This trade …
Huntington (HBAN) has been building a constructive technical base above rising short- and medium-term moving averages while fundamentals show reasonable valuation, consistent cash flow and a healthy dividend. This trade idea looks to capture a mid-term move back toward the 52-week high with a clear entry, stop and target and a balanced view of the …
Rackspace (RXT) plunged intraday to $4.41 on heavy volume after a stretch of strong 2026 rallies. The combination of a formalized AMD AI compute partnership (30 MW through 2028), a $75–85M run-rate cost reduction, and an expanding Middle East footprint creates a clear recovery path. This trade plan buys the dip with a $3.50 stop and a $8.00 target …
Broadcom is shifting from back-end supplier to front-line AI infrastructure partner as customers like OpenAI pursue custom chips. The stock trades at roughly $1.9T market cap with a P/E near 65 and $32.8B in free cash flow, leaving room for multiple expansion if AI design wins scale. This trade idea advocates a long position with an entry at $401.9…
Array Technologies ($6.52) is trading well below its 52-week high and peers despite steady cash generation and structural demand for ground-mounted solar trackers. This trade targets a mid-term reversion on improving execution and deal flow while respecting downside risks tied to project timing and sector sentiment.
Sabra Health Care REIT is reshaping its portfolio toward managed senior housing at a time when aging demographics are a structural tailwind. The stock pays a near-6% yield, trades at a modest P/B of ~1.8, and shows improving technical momentum. This trade plan targets $23.00 over a mid-term (45 trading days) horizon with a stop at $18.00 — balanced…
